Patents Assigned to Proteus Biomedical, Inc.
  • Patent number: 8055345
    Abstract: Various aspects of the present invention enable robust, reliable control functionality for effectors present on intraluminal, e.g., vascular leads, as well as other types of implantable devices. Aspects of the invention include implantable integrated circuits that have self-referencing and self-clocking signal encoding, and are capable of bidirectional communication. Also provided by the invention are effector assemblies that include the integrated circuits, as well as implantable medical devices, e.g., pulse generators that include the same, as well as systems and kits thereof and methods of using the same, e.g., in pacing applications, including cardiac resynchronization therapy (CRT) applications.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: November 8, 2011
    Assignee: Proteus Biomedical, Inc.
    Inventors: Haifeng Li, Mark Zdeblick, Lawrence Arne, Yafei Bi, Nilay Jani, Jonathan Withrington
  • Patent number: 8036743
    Abstract: One embodiment of the present invention provides a system for automatically optimizing CRT procedures using a multi-electrode pacing lead. During operation, the system performs a first set of iterations to select one or more satellites on one or more pacing leads inserted in a patient. A pacing lead includes a plurality of pacing satellites, and a pacing satellite includes a plurality of electrodes that can be individually addressed and used for transmitting or detecting electric signals. The system then performs a second set of iterations to select one or more electrodes on the selected satellites. The system further performs a third set of iterations to select one or more timing configurations for pacing signals transmitted through one or more of the selected electrodes.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: October 11, 2011
    Assignee: Proteus Biomedical, Inc.
    Inventors: George M. Savage, Todd Thompson, Mark J. Zdeblick, Lawrence W. Arne, Olivier Colliou, Benedict James Costello, Fataneh A. Omidvar
  • Patent number: 8036748
    Abstract: An ingestible therapy activator system and method are provided. In one aspect, the ingestible therapy activator includes an ingestible device having an effector module to send an effector instruction and a responder module associated with a therapeutic device. The responder module may receive and process the effector instruction, resulting in a response by the therapeutic device. Examples of responses by therapeutic device include activating a therapy, deactivating a therapy, modulating a therapy, and discontinuing a therapy.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: October 11, 2011
    Assignee: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, Marc Jensen, Olivier Colliou, Angela Strand
  • Publication number: 20110196454
    Abstract: Sensing system, device, and method for therapy modulation are provided. Various aspects include a receive module and a therapy-related action module. The receive module may receive a therapy parameter of an individual. The therapy-related action module may effectuate, based on the therapy parameter, a therapy-related action associated with a nervous system of the individual.
    Type: Application
    Filed: November 13, 2009
    Publication date: August 11, 2011
    Applicant: PROTEUS BIOMEDICAL, INC.
    Inventors: Angela Strand, Mark Zdeblick, George Savage, David O'reilly
  • Patent number: 7983751
    Abstract: A method for measuring the conduction velocity of a depolarization wave in a tissue employs a first satellite located within the tissue and a second that satellite is located within the tissue a distance away from the first satellite, e.g., by using the time of depolarization wave as reported from each satellite and the distance to determine velocity of the wave. Also provided are systems and kits that find use in accordance with the invention.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: July 19, 2011
    Assignee: Proteus Biomedical, Inc.
    Inventors: Mark J. Zdeblick, Timothy Robertson, George M. Savage
  • Patent number: 7978064
    Abstract: The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can be used in a variety of different applications, including as components of ingestible identifiers, such as may be found in ingestible event markers, e.g., pharma-informatics enabled pharmaceutical compositions.
    Type: Grant
    Filed: September 21, 2009
    Date of Patent: July 12, 2011
    Assignee: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, Timothy Robertson, Aleksandr Pikelny, Hooman Hafezi
  • Patent number: 7974705
    Abstract: Implantable stimulation devices are provided. Aspects of the devices include a multiplexed multi-electrode component configured for neural stimulation. The multiplexed multi-electrode component includes two or more individually addressable satellite electrode structures electrically coupled to a common conductor. The satellite structures include a hermetically sealed integrated circuit controller operatively coupled to one or more electrodes. Also provided are systems that include the devices of the invention, as well as methods of using the systems and devices in a variety of different applications.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: July 5, 2011
    Assignee: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, Todd Thompson, Marc Jensen, Olivier Colliou, Angela Strand
  • Publication number: 20110130809
    Abstract: System, device and method of variable pacing and stimulation are provided. In one example device, one or more lead integrated circuits may programmably control one or more variability parameters. One or more electrodes may provide electrical stimulation. Each electrode may be individually addressable by at least one of the lead integrated circuits and controlled by at least one variability parameter. Electrodes may be intentionally shorted together during time intervals that fall between times of stimulus, so as to dissipate potentials that might otherwise persist and cause electrode degradation.
    Type: Application
    Filed: November 13, 2009
    Publication date: June 2, 2011
    Applicant: PROTEUS BIOMEDICAL, INC.
    Inventor: Mark Zdeblick
  • Patent number: 7935056
    Abstract: Techniques for controlling one or more modular circuits (“satellites”) that are intended for placement in a subject's body. The one or more satellites are controlled by sending signals over a bus that includes first and second conduction paths. Also coupled to the bus in system embodiments is a device such as a pacemaker that provides power and includes control circuitry. Each satellite includes satellite circuitry and one or more effectors that interact with the tissue. The satellite circuitry is coupled to the bus, and thus interfaces the controller to the one or more effectors, which may function as actuators, sensors, or both. The effectors may be electrodes that are used to introduce analog electrical signals (e.g., one or more pacing pulses) into the tissue in the local areas where the electrodes are positioned (e.g., heart muscles) or to sense analog signals (e.g., a propagating depolarization signal) within the tissue.
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: May 3, 2011
    Assignee: Proteus Biomedical, Inc.
    Inventor: Mark J. Zdeblick
  • Patent number: 7925329
    Abstract: The inventive implantable Doppler tomography system allows, for the first time, the use of Doppler shift for purposes of tracking cardiac wall motion. The present inventive Doppler tomography system methods and devices provide a critical new tool in the physician's armamentarium which provides accurate, real time monitoring of the mechanical performance of the heart.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: April 12, 2011
    Assignee: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, George M. Savage
  • Patent number: 7877149
    Abstract: Methods of using electrodes to obtain physiological location motion data are provided. Embodiments of the methods include producing an electrode from a broadcasting electrode that is proximal to the physiological location of interest and detecting a change in an induced electric potential at a receiving electrode to obtain the motion data of interest. Also provided are systems and components thereof, e.g., programming, for practicing methods according to embodiments of the invention.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: January 25, 2011
    Assignee: Proteus Biomedical Inc.
    Inventor: Mark Zdeblick
  • Patent number: 7837634
    Abstract: Devices and methods for evaluating motion of a tissue location, such as cardiac tissue location, e.g., heart wall, are provided. Devices employed in the subject methods are fiberoptic tissue motion sensors that include a light guide having a reflective element at its distal end and a light emitter/detector at its proximal end. In embodiments of the methods, a signal obtained from reflective element stably associated with the tissue location of interest is employed to evaluate movement of the tissue location. The subject methods and devices find use in a variety of different applications, including cardiac resynchronization therapy.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: November 23, 2010
    Assignee: Proteus Biomedical, Inc.
    Inventor: Benedict James Costello
  • Publication number: 20100249883
    Abstract: Techniques for controlling one or more modular circuits (“satellites”) that are intended for placement in a subject's body. The one or more satellites are controlled by sending signals over a bus that includes first and second conduction paths. Also coupled to the bus in system embodiments is a device such as a pacemaker that provides power and includes control circuitry. Each satellite includes satellite circuitry and one or more effectors that interact with the tissue. The satellite circuitry is coupled to the bus, and thus interfaces the controller to the one or more effectors, which may function as actuators, sensors, or both. The effectors may be electrodes that are used to introduce analog electrical signals (e.g., one or more pacing pulses) into the tissue in the local areas where the electrodes are positioned (e.g., heart muscles) or to sense analog signals (e.g., a propagating depolarization signal) within the tissue.
    Type: Application
    Filed: March 11, 2010
    Publication date: September 30, 2010
    Applicant: Proteus Biomedical, Inc.
    Inventor: Mark J. Zdeblick
  • Patent number: 7771363
    Abstract: The present invention provides a new mechanical sensor approach to maneuvering catheters and other cardiac devices into blood outlets, with particular application to maneuvering cardiac devices into the coronary sinus and beyond. Additionally, the inventive sensing device provides assessment of the viability of branching veins and other potential device sites, such as within the coronary venous system.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: August 10, 2010
    Assignee: Proteus Biomedical, Inc.
    Inventor: Todd Thompson
  • Patent number: 7762138
    Abstract: Implantable pressure sensors and methods for making and using the same are provided. A feature of embodiments of the subject pressure sensors is that they are low-drift sensors. The subject sensors find use in a variety of applications.
    Type: Grant
    Filed: June 11, 2008
    Date of Patent: July 27, 2010
    Assignee: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, Lawrence Arne, Nilay Jani, Haifeng Li
  • Patent number: 7738958
    Abstract: Methods, apparatus and systems for enhancing cardiac pacing generally provide for measuring at least one cardiac characteristic, calculating at least one cardiac performance parameter based on the measured characteristic(s), and adjusting at least one functional parameter of a cardiac pacing device. Devices may include at least one catheter (such as a multiplexed catheter with one or more sensors and/or actuators), at least one implant (such as a sensor implantable in a heart wall), or a combination of both. Various cardiac performance parameters and/or pacing device performance parameters may be weighted, and the parameters and their respective weights may be used to determine one or more adjustments to be made to the pacing device. In some instances, the adjustments are made automatically.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: June 15, 2010
    Assignee: Proteus Biomedical, Inc.
    Inventors: Mark Zdeblick, Joseph M. Ruggio
  • Patent number: 7729768
    Abstract: Implantable cardiac motion powered piezoelectric energy sources are provided. An aspects of embodiments of the subject implantable energy sources is that they include a piezoelectric transducer that converts cardiac mechanical energy to electrical energy. The subject energy sources find use in a variety of applications, including providing power to a wide range of implantable devices.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: June 1, 2010
    Assignee: Proteus Biomedical, Inc.
    Inventors: Robert White, George Savage, Mark Zdeblick
  • Patent number: 7713194
    Abstract: Techniques for controlling one or more modular circuits (“satellites”) that are intended for placement in a subject's body. The one or more satellites are controlled by sending signals over a bus that includes first and second conduction paths. Also coupled to the bus in system embodiments is a device such as a pacemaker that provides power and includes control circuitry. Each satellite includes satellite circuitry and one or more effectors that interact with the tissue. The satellite circuitry is coupled to the bus, and thus interfaces the controller to the one or more effectors, which may function as actuators, sensors, or both. The effectors may be electrodes that are used to introduce analog electrical signals (e.g., one or more pacing pulses) into the tissue in the local areas where the electrodes are positioned (e.g., heart muscles) or to sense analog signals (e.g., a propagating depolarization signal) within the tissue.
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: May 11, 2010
    Assignee: Proteus Biomedical, Inc.
    Inventor: Mark J. Zdeblick
  • Patent number: 7713195
    Abstract: Techniques for controlling one or more modular circuits (“satellites”) that are intended for placement in a subject's body. The one or more satellites are controlled by sending signals over a bus that includes first and second conduction paths. Also coupled to the bus in system embodiments is a device such as a pacemaker that provides power and includes control circuitry. Each satellite includes satellite circuitry and one or more effectors that interact with the tissue. The satellite circuitry is coupled to the bus, and thus interfaces the controller to the one or more effectors, which may function as actuators, sensors, or both. The effectors may be electrodes that are used to introduce analog electrical signals (e.g., one or more pacing pulses) into the tissue in the local areas where the electrodes are positioned (e.g., heart muscles) or to sense analog signals (e.g., a propagating depolarization signal) within the tissue.
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: May 11, 2010
    Assignee: Proteus Biomedical, Inc.
    Inventor: Mark J. Zdeblick
  • Publication number: 20100114250
    Abstract: Techniques for controlling one or more modular circuits (“satellites”) that are intended for placement in a subject's body. The one or more satellites are controlled by sending signals over a bus that includes first and second conduction paths. Also coupled to the bus in system embodiments is a device such as a pacemaker that provides power and includes control circuitry. Each satellite includes satellite circuitry and one or more effectors that interact with the tissue. The satellite circuitry is coupled to the bus, and thus interfaces the controller to the one or more effectors, which may function as actuators, sensors, or both. The effectors may be electrodes that are used to introduce analog electrical signals (e.g., one or more pacing pulses) into the tissue in the local areas where the electrodes are positioned (e.g., heart muscles) or to sense analog signals (e.g., a propagating depolarization signal) within the tissue.
    Type: Application
    Filed: November 23, 2009
    Publication date: May 6, 2010
    Applicant: Proteus Biomedical, Inc.
    Inventor: Mark J. Zdeblick